PHATHOM PHARMACEUTICALS, INC. (PHAT) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$3.85M*; Operating income -$3.96M; Depreciation and amortization $114.00K*.
- 2026-03-31: Basis Reported; EBITDA -$15.37M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$5.8M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$15.12M*; Operating income -$15.27M; Depreciation and amortization $156.00K*.
Complete source-backed ebitda history.
- Available history
- 2019-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$3.85M* | -$3.96M | $114.00K* | (m) | (m) | $44.00K* | -$1.93M* | (m) | $7.81M | $55.33M | (m) |
|---|
| 2026-03-31 | Reported | -$15.37M | (m) | (m) | (m) | -26.36% | $61.00K | -$15.65M | (m) | $7.77M | $54.01M | (m) |
|---|
| 2025-12-31 | Reported | -$5.8M | (m) | (m) | (m) | -10.07% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$15.12M* | -$15.27M | $156.00K* | (m) | (m) | $27.00K* | -$14.12M* | (m) | $7.03M | $51.56M | (m) |
|---|
| 2025-06-30 | Reported | -$59.75M* | -$59.92M | $172.00K* | (m) | (m) | $97.00K* | -$62.73M* | (m) | $9.08M | $85.31M | (m) |
|---|
| 2025-03-31 | Reported | -$78.69M | (m) | (m) | (m) | -275.91% | $18.00K | -$84.93M | (m) | $9.18M | $94.47M | (m) |
|---|
| 2024-12-31 | Reported | -$59.22M | (m) | (m) | (m) | -199.65% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$70.61M* | -$70.80M | $191.00K* | (m) | (m) | $44.00K* | -$63.57M* | (m) | $8.69M | $76.10M | (m) |
|---|
| 2024-06-30 | Reported | -$77.10M* | -$77.30M | $197.00K* | (m) | (m) | $46.00K* | -$70.72M* | (m) | $7.38M | $75.87M | (m) |
|---|
| 2024-03-31 | Reported | -$69.74M | (m) | (m) | (m) | -3647.49% | $40.00K | -$69.02M | (m) | $9.43M | $62.01M | (m) |
|---|
| 2023-12-31 | Reported | -$69.69M | (m) | (m) | (m) | -10218.48% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$35.54M* | -$35.66M | $121.00K* | (m) | (m) | $939.00K* | -$31.91M* | (m) | $12.26M | $23.40M | (m) |
|---|
| 2023-06-30 | Reported | -$31.58M* | -$31.70M | $123.00K* | (m) | (m) | $6.00K* | -$22.20M* | (m) | $12.76M | $18.94M | (m) |
|---|
| 2023-03-31 | Reported | -$29.93M | (m) | (m) | (m) | (m) | $214.00K | -$39.67M | (m) | $11.48M | $18.60M | (m) |
|---|
| 2022-12-31 | Reported | -$46.47M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$42.35M* | -$42.53M | $175.00K* | (m) | (m) | $134.00K* | -$35.02M* | (m) | $19.02M | (m) | (m) |
|---|
| 2022-06-30 | Reported | -$45.21M* | -$45.36M | $149.00K* | (m) | (m) | $428.00K* | -$25.72M* | (m) | $18.82M | (m) | (m) |
|---|
| 2022-03-31 | Reported | -$37.78M | (m) | (m) | (m) | (m) | $67.00K | -$44.76M | (m) | $17.66M | (m) | (m) |
|---|
| 2021-12-31 | Reported | -$32.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$33.01M* | -$33.14M | $130.00K* | (m) | (m) | $14.00K* | -$29.07M* | (m) | $16.61M | (m) | (m) |
|---|
| 2021-06-30 | Reported | -$35.19M* | -$35.32M | $131.00K* | (m) | (m) | $45.00K* | -$28.36M* | (m) | $21.60M | (m) | (m) |
|---|
| 2021-03-31 | Reported | -$33.46M | (m) | (m) | (m) | (m) | $169.00K | -$49.77M | (m) | $20.58M | (m) | (m) |
|---|
| 2020-12-31 | Reported | -$52.33M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $41.65M | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$32.74M* | -$32.83M | $88.00K* | (m) | (m) | $183.00K* | -$20.73M* | (m) | $25.77M | (m) | (m) |
|---|
| 2020-06-30 | Reported | -$19.94M* | -$20.02M | $77.00K* | (m) | (m) | $57.00K* | -$9.34M* | (m) | $14.86M | (m) | (m) |
|---|
| 2020-03-31 | Reported | -$20.32M | (m) | (m) | (m) | (m) | $676.00K | -$11.42M | (m) | $15.87M | (m) | (m) |
|---|
| 2019-12-31 | Reported | -$15.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $12.70M | (m) | (m) |
|---|
| 2019-09-30 | Reported | (m) | -$6.28M | (m) | (m) | (m) | (m) | -$7.11M* | (m) | $4.47M | (m) | (m) |
|---|
| 2019-06-30 | Reported | (m) | -$83.01M | (m) | (m) | (m) | (m) | -$5.21M* | (m) | $2.77M | (m) | (m) |
|---|
| 2019-03-31 | Reported | (m) | -$1.23M | (m) | (m) | (m) | (m) | -$807.00K | (m) | $429.00K | (m) | (m) |
|---|
| 2018-12-31 | Reported | (m) | -$451.00K | (m) | (m) | (m) | (m) | (m) | (m) | $14.00K | (m) | (m) |
|---|
| 2018-09-30 | Reported | (m) | -$268.00K | (m) | (m) | (m) | (m) | (m) | (m) | $6.00K | (m) | (m) |
|---|
| 2018-06-30 | Reported | (m) | -$255.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2018-03-31 | Reported | (m) | -$251.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$159.35M | (m) | (m) | (m) | -91.00% | $229.00K | -$166.78M | (m) | $32.78M | $279.72M | $0.00 |
|---|
| 2024-12-31 | Reported | -$276.67M | (m) | (m) | (m) | -500.75% | $135.00K | -$266.77M | (m) | $34.08M | $290.66M | $0.00 |
|---|
| 2023-12-31 | Reported | -$166.74M | (m) | (m) | (m) | -24448.24% | $1.63M | -$137.58M | (m) | $49.90M | $117.93M | $0.00 |
|---|
| 2022-12-31 | Reported | -$171.82M | (m) | (m) | (m) | (m) | $1.04M | -$146.53M | (m) | $71.44M | $101.00M | $0.00 |
|---|
| 2021-12-31 | Reported | -$134.56M | (m) | (m) | (m) | (m) | $328.00K | -$148.46M | (m) | $72.34M | (m) | $0.00 |
|---|
| 2021-09-30 | Rolling | (m) | -$154.48M* | (m) | (m) | (m) | (m) | (m) | (m) | $100.44M* | (m) | (m) |
|---|
| 2021-06-30 | Rolling | (m) | -$154.17M* | (m) | (m) | (m) | (m) | (m) | (m) | $109.60M* | (m) | (m) |
|---|
| 2021-03-31 | Rolling | (m) | -$138.87M* | (m) | (m) | (m) | (m) | (m) | (m) | $102.86M* | (m) | (m) |
|---|
| 2020-12-31 | Reported | -$125.34M | (m) | (m) | (m) | (m) | $1.04M | -$69.69M | (m) | $98.15M | (m) | $0.00 |
|---|
| 2020-12-31 | Rolling | (m) | -$125.67M* | (m) | (m) | (m) | (m) | (m) | (m) | $98.15M* | (m) | (m) |
|---|
| 2020-09-30 | Rolling | (m) | -$88.92M* | (m) | (m) | (m) | (m) | (m) | (m) | $69.20M* | (m) | (m) |
|---|
| 2020-06-30 | Rolling | (m) | -$62.37M* | (m) | (m) | (m) | (m) | (m) | (m) | $47.90M* | (m) | (m) |
|---|
| 2020-03-31 | Rolling | (m) | -$125.36M* | (m) | (m) | (m) | (m) | (m) | (m) | $35.81M* | (m) | (m) |
|---|
| 2019-12-31 | Reported | -$106.21M | (m) | (m) | (m) | (m) | $132.00K | -$36.51M | (m) | $20.37M | (m) | $0.00 |
|---|
| 2019-12-31 | Rolling | (m) | -$106.22M* | (m) | (m) | (m) | (m) | (m) | (m) | $20.37M* | (m) | (m) |
|---|
| 2019-09-30 | Rolling | (m) | -$90.97M* | (m) | (m) | (m) | (m) | (m) | (m) | $7.68M* | (m) | (m) |
|---|
| 2019-06-30 | Rolling | (m) | -$84.96M* | (m) | (m) | (m) | (m) | (m) | (m) | $3.22M* | (m) | (m) |
|---|
| 2019-03-31 | Rolling | (m) | -$2.20M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2018-12-31 | Reported | (m) | -$1.23M | (m) | (m) | (m) | (m) | -$1.02M | (m) | $20.00K | (m) | $0.00 |
|---|
| 2018-12-31 | Rolling | (m) | -$1.23M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|